Biomarkers for Metformin and Myo-inositol Drug Response in Polycystic Ovarian Syndrome
Not Applicable
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2024/08/071982
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Females in the age group of 18-30 years
2. Those who have attained menarche
3. Patients diagnosed with PCOS as per Rotterdam diagnostic criteria (2003)
Exclusion Criteria
1. Females in the age group of below 18 years and above 30 years of age
2. Those who have not attained menarche
3. Patients diagnosed with any chronic illness except Diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HOMA IR (Homeostatic Model Assessment for Insulin Resistance) and ultrasound scanningTimepoint: Before the onset of drug treatment
- Secondary Outcome Measures
Name Time Method HOMA IR level is recheckedTimepoint: After 3 months of drug treatment